WebMar 8, 2024 · Trulieve Reports Fourth Quarter and Record Full Year 2024 Results Exceeding $1.2 Billion in Revenue. News provided by. Trulieve Cannabis Corp. Mar 08, 2024, 06:00 … WebDec 15, 2024 · Trulieve’s stock looks pretty attractive at the moment as its forward EV/EBITDA ratio is only 8.6x, compared to its historical average of 11.2x. Furthermore, its P/E ratio is 27.4x, compared to ...
Trulieve Cannabis (TRUL) Stock Forecast & Price Target - TipRanks
WebTCNNF Stock 12 Months Forecast. Based on 3 Wall Street analysts offering 12 month price targets for Trulieve Cannabis in the last 3 months. The average price target is $12.50 with … Web2. Short to Medium term bearish for TCNNF. Despite tailwinds for Cannabis legalisation in US, the technical chart of TCNNF shows potential retest of 14.5$ region in the near term. … cancer alliance of health and hope
Where will Trulieve Cannabis Stock Be In 1 Year? – Financhill
WebJan 9, 2024 · Trulieve Cannabis (OTC: TCNNF) Based in Quincy, Florida, Trulieve cultivates, distributes, and retails medical cannabis in the U.S. With a market cap of $959.1 million, the firm offers a suite of Trulieve branded products, including nasal sprays, capsules, concentrates, syringes, and cannabis flower in containers for vaporizers, topical creams, … WebFeb 24, 2024 · Trulieve Cannabis Corp. (the "Company") ceased to qualify as an emerging growth company and became a large accelerated filer effective as of December 31, … WebApr 12, 2024 · 9 equities research analysts have issued 12-month price objectives for Cresco Labs' shares. Their CRLBF share price forecasts range from $2.50 to $14.25. On average, they anticipate the company's share price to reach $6.82 in the next twelve months. This suggests a possible upside of 357.8% from the stock's current price. fishing store westerly ri